Influence of β - cyclodextrin complexation on lovastatin release from osmotic pump tablets (OPT)

Daru

Volumn 15, Issue 2, 2007, Pages 71-78

  Mehramizi, A ^a,b   Asgari Monfared, E ^a   Pourfarzib, M ^c   Bayati, Kh ^a   Dorkoosh, F A ^d   Rafiee Tehrani, M ^a  

^a Tehran University of Medical Sciences   (Iran)

^b Tehran Chemie Pharmaceutical Co   (Iran)

^c MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

^d ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

cyclodextrin; Elementary osmotic pump; Inclusion complex; Lovastatin

Indexed keywords

BETA CYCLODEXTRIN; CELLULOSE ACETATE; DODECYL SULFATE SODIUM; LACTOSE; MACROGOL; MACROGOL 300; MAGNESIUM STEARATE; MEVINOLIN; PLASTICIZER; POLYMER; POVIDONE; STARCH; TALC; TRIACETIN; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; COMPLEX FORMATION; CONTROLLED DRUG RELEASE; DRUG SOLUBILITY; HYDROPHILICITY; MOLECULAR WEIGHT; OSMOTIC PUMP; TABLET FORMULATION;

EID: 34447546764     PISSN: 15608115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Theeuwes F. Elementary osmotic pump. J Pharm Sci 1975; 64: 1987-1991.
2. Theeuwes F, Higuchi T. Osmotic dispensing device for releasing beneficial agent. US patent 3,845,770. 1972.
3. McClelland G A, Sulton S C, Engle K, Zentner G M. The solubility-modulated osmotic pump: invitro / invivo release of diltiazem hydrochloride. Pharma Res 1991; 8: 88-92.
4. Kharmnna S C, Therapeutic system for sparingly soluble active ingredients. US patent 4,992,278. 1991.
5. Swanson D R, Barclay B L, Wong P S L, Theeuwes F. Nifedipine gastrointestinal Therapeutic system. Am J Med 1987; 83: 3-9.
6. Theeuwes F. Osmotic system for delivering selected beneficial agents having varying degrees of solubility. US patent 4,111,201. 1978.
7. Kuczynski A L, Ayer A D, Wong P S. Dosage form for administering oral hypoglycemic glipizide. US patent 5,545,413. 1997.
8. Geerke J H. Method and apparatus for forming dispenser delivery ports. US patent 5,658,474. 1997.
9. Herbig S M, Cardinal J R, Korsmeyer R W, Smith K L. Asymmetric-membrane tablet coating for osmotic drug delivery. J Control Rel 1995; 35: 127-136.
10. Yalkowsky S H. Techniques of solubilization of drugs. New York: Marcel Dekker; 1981.p.234.
11. Uekama K, Otagiri M. Cyclodextrins in drug carrier systems. Crit RevTher Drug Carrier Sys 1987; 31-40.
12. Szejtli J. Medicinal applications of cyclodextrins. Med Res Rev 1994; 14: 353-386.
13. Thomson D. Cyclodextrins - enabling excipients: their present and future use in pharmaceuticals. Crit Rev Ther Drug Carrier Sys 1997; 14: 1-104.
14. Stella V J, Rajeswski R A. Cyclodextrins: their future in drug formulation and delivery. Pharm. Res. 1997; 14: 556-567.
15. Irie T, Uekama K. Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation. J Pharm Sci 1997; 86: 147-162.
16. Uekama K, Hirayama F, Irie T. Cyclodextrin drug carrier systems. Chem Rev 1998; 98: 2045-2076.
17. Loftsson T. Increasing the cyclodextrin complexation of drugs and drug bioavailability through addition of water-soluble polymers. Pharmazie 1998; 53: 733-740.
18. Challa R, Ahuja A, Ali J, Khar R K. Cyclodextrins in drug delivery: An updated review. AAPS Pharm Sci Tech 2005; 6: 329-357.
19. 7 m - β- CD as both a solubilizing and an osmotic pump agent. J Control Rel 1999; 58: 29-38.
20. 7m - β- CD. Pharm Res 1998; 15: 1562-1568.
21. 7m - β- CD . Pharm Res 1999;16: 549-554.
22. 7m - β- CD in controlled-porosity osmotic pump tablets(OPTS). Int J Pharma 2004; 286: 81-88.
23. Gan Y, Pan W, Wei M, Zhang R. Cyclodextrin complex osmotic tablet for glipizide delivery. Drug Dev Ind Pharm 2002; 28: 1015-1021.
24. Higuchi T K, Connors A. Phase-solubility techniques. Adva Chem Instr 1965; 4: 212-217.
25. The Merck Index, 13th edn., USA: Merck&Co.,Inc. 2001.p.5610.
26. Szetli J. Molecular entrapment and release properties of drugs by Cyclodextrins. Controlled drug bioavailability: Bioavailability control by drug delivery system design. Vol. 3. Wiley Interscience publication. 1985; 365-556.
27. Shah V P, Noory A, Noory C, McCullough B, Clarke S, Everett R, Naviasky H, Srinivasan B N, Fortman D, Skelly J P. In vitro dissolution of sparingly water-soluble drug dosage forms. Int J Pharm 1995; 125:99-106.
28. Liu L, Khang G, Rhee J M, Lee H B. Monolithic osmotic tablet system for nifedipine delivery. J Control Rel 2000; 67: 309-322.
29. Lu E X, Jiang Z Q, Zhang Q Z, Jiang X G. A water-insoluble drug monolithic osmotic tablet system utilizing gum Arabic as osmotic, suspending and expanding agent. J Control Rel 2003; 92: 375-382.
30. Theeuwes F, Swanson D, Wong P, Bonsen P, Place V, Heimlich K, Kwan K C. Elementary osmotic pump for indometacin, J Pharm Sci 1983; 72: 253-258.